Home
Atlas Venture Fund XI, 10% Owner: Xilio Therapeutics XLO Sell · Filed 24/02/09
Trade details
- Type
- Insider sale
- Amount
- $469.12
- Shares · price
- 733 sh · $0.64 a share
- Held after
- 2,019,563 sh
- Trade date
- 24/02/08
- Filed
- 24/02/09
- Days to filing
- 1 days
Sold under 0.1% of holdings
- Share of holding sold
- under 0.1%
Xilio Therapeutics trades, last 26 weeks
What else happened in Xilio Therapeutics around then
Filed or reported within 30 days of the trade day · 24/01/09~24/03/09Atlas Venture Fund XI's recent trades
- Atlas Venture Fund XI
Planned sale10b5-1 planKorro Bio
Planned sale10b5-1 planKorro Bio
KRRO
$440.4K
31,888 sh
$440.4K
Filed 09/14
Traded 09/14
- Atlas Venture Fund XI
Planned sale10b5-1 planKorro Bio
Planned sale10b5-1 planKorro Bio
KRRO
$110.4K
8,450 sh
$110.4K
Filed 09/11
Traded 09/11
- Atlas Venture Fund XI
Planned sale10b5-1 planKorro Bio
Planned sale10b5-1 planKorro Bio
KRRO
$3,419
249 sh
$3,419
Filed 08/26
Traded 08/26
- Atlas Venture Fund XI
Planned sale10b5-1 planKorro Bio
Planned sale10b5-1 planKorro Bio
KRRO
$311.8K
23,584 sh
$311.8K
Filed 08/19
Traded 08/19
- Atlas Venture Fund XI
Planned sale10b5-1 planDyne Therapeutics
Planned sale10b5-1 planDyne Therapeutics
DYN
$35.3M
1,359,674 sh
$35.3M
Filed 08/14
Traded 08/14
